National Disease Research Interchange

Analysis

National Disease Research Interchange is a registered charity in United States, based in Philadelphia, PA. It received its IRS tax-exemption ruling in August 1982, 44 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (gross receipts test) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, National Disease Research Interchange reported income of $9.1m and spending of $9.3m, spending 101% of its income. Across the 5 years on record, from December 2019 to December 2023, income grew from $7.1m to $9.1m (+28%), an average of +6.5% a year. The sharpest change came in the year to December 2023, when income rose by 24%. Over the whole period it spent 104% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, National Disease Research Interchange sits at the 83rd percentile: it is larger than about 83% of them. Against every charity in United States with reported income it ranks in the 95th percentile, and in the 93rd percentile within PA. Charities of a similar size with the same main cause include District of Columbia Primary Care Association ($9.1m), Uni Care Hospice Inc ($9.1m) and Open Cities Health Center Inc ($9.1m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 51% and program service revenue 48% of the total. Compensation of current officers, directors and key employees was $626k (6.8% of expenses). Other salaries and wages came to $2.4m. At year end it held assets of $7.2m against liabilities of $5.4m, net assets of $1.8m. It reported 41 employees.